Detalles de la búsqueda
1.
Efficacy and safety of RGB-02, a pegfilgrastim biosimilar to prevent chemotherapy-induced neutropenia: results of a randomized, double-blind phase III clinical study vs. reference pegfilgrastim in patients with breast cancer receiving chemotherapy.
BMC Cancer
; 19(1): 122, 2019 Feb 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30727980
2.
Febrile neutropenia (FN) and pegfilgrastim prophylaxis in breast cancer and non-Hodgkin's lymphoma patients receiving high (> 20%) FN-risk chemotherapy: results from a prospective observational study.
Support Care Cancer
; 27(4): 1449-1457, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30259136
3.
Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study.
Breast Cancer Res Treat
; 167(3): 671-686, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29063313
4.
Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer.
N Engl J Med
; 369(11): 1023-34, 2013 Sep 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-24024839
5.
A Randomized, Double-Blind, Placebo-Controlled, Phase III Noninferiority Study of the Long-Term Safety and Efficacy of Darbepoetin Alfa for Chemotherapy-Induced Anemia in Patients With Advanced NSCLC.
J Thorac Oncol
; 15(2): 190-202, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31629060
6.
Avelumab monotherapy as first-line or second-line treatment in patients with metastatic renal cell carcinoma: phase Ib results from the JAVELIN Solid Tumor trial.
J Immunother Cancer
; 7(1): 275, 2019 10 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-31651359
7.
Phase I/II study of pemetrexed with or without ABT-751 in advanced or metastatic non-small-cell lung cancer.
J Clin Oncol
; 29(8): 1075-82, 2011 Mar 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-21300929
8.
Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study.
J Clin Oncol
; 28(31): 4697-705, 2010 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20921465
9.
Darbepoetin alpha for the treatment of anemia in patients with active cancer not receiving chemotherapy or radiotherapy: results of a phase III, multicenter, randomized, double-blind, placebo-controlled study.
J Clin Oncol
; 26(7): 1040-50, 2008 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18227526
10.
Phase III trial comparing paclitaxel poliglumex (CT-2103, PPX) in combination with carboplatin versus standard paclitaxel and carboplatin in the treatment of PS 2 patients with chemotherapy-naïve advanced non-small cell lung cancer.
J Thorac Oncol
; 3(6): 623-30, 2008 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-18520802
Resultados
1 -
10
de 10
1
Próxima >
>>